No Data
Prism Biolab: Summary of financial results for the 1st quarter of the fiscal year ending September 2025 [Japanese GAAP] (unconsolidated)
Kirin HD, Matsukiyo Cocok, Dentsu Group, Rakuten Group (14th) (1379-5368)
The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- February 14 (Friday) <1379> Hokuto <1380> Akigawa Boku-en <1417> Mirait-Wan <142A> Jinjibu <1438> Gifu Landscaping <1443> Giken HD <1447> SAAF HD <145A> Elizbee<
The Tokyo Stock Exchange Growth Index has continued to decline, with selling remaining dominant.
Tokyo Stock Exchange Growth Market Index 804.01 -4.75 / Volume 0.1 billion 71.15 million shares / Trading value 119.6 billion yen. Tokyo Stock Exchange Growth Market 250 Index 625.85 -4.01 / Volume 0.1 billion 17.45 million shares / Trading value 98.8 billion yen. Today's growth market saw both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index continuing to decline, with 229 rising stocks, 323 falling stocks, and 50 unchanged. The growth market today performed sluggishly. Dow Inc in the USA market.
Express News | [Change Report] Life Science Venture Capital reports a decrease in the shareholding of PRISM BioLab (206A.JP) to 5.3%.
Volume change rate ranking (9 AM) - Nextage, J-ATC, etc. are ranked.
In the volume change rate ranking, by comparing the average volume over the last 5 days with the volume on the day of distribution, it is possible to understand market participants' interests and trends in buying and selling. ■Top volume change rates [As of January 7, 9:36] (Comparison of average volume over the last 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <5572> Ridge Eye 7100 107185.08 -80.45% 0.0038%<
PRISM BioLab [Unlock Schedule]
■PRISM BioLab <206A> Estimated number of shares to be released: 7,669,400 shares (estimated) Release date: 2024/12/29 Target Shareholders : Estimated Shares Takehara Dai: 726,000 shares Nakashima Kiichiro: 1,872,000 shares Ohara Pharmaceutical Industry Co., Ltd.: 1,000,000 shares Takeda Hideki: 935,000 shares MediPal Holdings Co., Ltd.